{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:30:08Z","timestamp":1789965008377,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04479-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:35:58Z","timestamp":1764074158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cefuroxime-related hemorrhagic retinal vasculitis following cataract surgery"],"prefix":"10.1186","volume":"25","author":[{"given":"Neslisah","family":"Kutlu Uzakgider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Karaca Adiyeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"10","key":"4479_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ophtha.2009.03.014","volume":"116","author":"E Sharifi","year":"2009","unstructured":"Sharifi E, Porco TC, Naseri A. Cost-effectiveness analysis of intracameral Cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology. 2009;116(10):1887\u2013e18961.","journal-title":"Ophthalmology"},{"issue":"6","key":"4479_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","volume":"28","author":"PG Montan","year":"2002","unstructured":"Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28(6):977\u201381.","journal-title":"J Cataract Refract Surg"},{"key":"4479_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","volume":"32","author":"P Barry","year":"2006","unstructured":"Barry P, Seal D, Gettinby G, Lees F, Peterson M, Revie CW, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary results from a European multicenter study. J Cataract Refract Surg. 2006;32:407\u201310.","journal-title":"J Cataract Refract Surg"},{"key":"4479_CR4","first-page":"1499","volume":"4","author":"PT Lam","year":"2010","unstructured":"Lam PT, Rao SK, Cheng AC, Leung AT, Lam DS. Randomized controlled trial on the safety of intracameral cephalosporins in cataract surgery. Clin Ophthalmol. 2010;4:1499\u2013504.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"4479_CR5","first-page":"1182","volume":"43","author":"AK Kwok","year":"2002","unstructured":"Kwok AK, Li WW, Pang CP, Yip SP, Lam DS. An in vitro study of Ceftazidime and Vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci. 2002;43(4):1182\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4479_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/112067219300300202","volume":"3","author":"S Koul","year":"1993","unstructured":"Koul S, Philip VM, Pathak R, Chopra RN. Intraocular levels of Cefuroxime in inflamed rabbit eyes. Eur J Ophthalmol. 1993;3(2):61\u20135.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"4479_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10633-014-9465-7","volume":"130","author":"C Faure","year":"2015","unstructured":"Faure C, Perreira D, Audo I. Retinal toxicity after intracameral use of a standard dose of Cefuroxime during cataract surgery. Doc Ophthalmol. 2015;130(1):57\u201363.","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"4479_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1167\/iovs.11-8053","volume":"53","author":"J Shahar","year":"2012","unstructured":"Shahar J, Melamed S, Goldenberg-Cohen N, Barak A. Physiological and toxicological effects of Cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci. 2012;53(2):906\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"4479_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","volume":"124","author":"AJ Witkin","year":"2017","unstructured":"Witkin AJ, Chang DF, Jumper JM, Charles S, Chiang A, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583\u201395.","journal-title":"Ophthalmology"},{"key":"4479_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Endophthalmitis Vitrectomy Study Group","year":"1995","unstructured":"Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479\u201396.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"4479_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ajo.2013.10.018","volume":"157","author":"S \u00c7ift\u00e7i","year":"2014","unstructured":"\u00c7ift\u00e7i S, \u00c7ift\u00e7i L, Da\u011f U. Hemorrhagic retinal infarction due to inadvertent overdose of Cefuroxime in cases of complicated cataract surgery: retrospective case series. Am J Ophthalmol. 2014;157(2):421\u2013e4252.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4479_CR12","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.1038\/s41598-019-46236-2","volume":"9","author":"H Miyake","year":"2019","unstructured":"Miyake H, Miyazaki D, Shimizu Y, Sasaki SI, Baba T, Inoue Y, Matsuura K. Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and Vancomycin on retinal vascular cells. Sci Rep. 2019;9(1):9745.","journal-title":"Sci Rep"},{"issue":"11","key":"4479_CR13","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jcrs.2016.09.013","volume":"42","author":"MA Miller","year":"2016","unstructured":"Miller MA, Scott IU, Flynn HW Jr, Smiddy WE, Berrocal AM, Davis JL, et al. Postoperative hemorrhagic occlusive retinal vasculitis associated with intracameral Vancomycin prophylaxis during cataract surgery. J Cataract Refract Surg. 2016;42(11):1676\u201380.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"4479_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","volume":"33","author":"SV Reddy","year":"2018","unstructured":"Reddy SV, Husain D. Panretinal photocoagulation: A review of complications. Semin Ophthalmol. 2018;33(1):83\u20138.","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"4479_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"K Ghasemi Falavarjani","year":"2013","unstructured":"Ghasemi Falavarjani K, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013;27(7):787\u201394.","journal-title":"Eye (Lond)"},{"key":"4479_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2147\/OPTH.S47629","volume":"7","author":"K Matsuura","year":"2013","unstructured":"Matsuura K, Inoue Y, Sasaki SI, Hata Y, Ohmura N, Gotou T. Assessment of vitreous drug concentration in the Porcine eye following intracameral injection or irrigation with Moxifloxacin. Clin Ophthalmol. 2013;7:1397\u2013402.","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"4479_CR17","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.ophtha.2005.05.020","volume":"112","author":"P Lalitha","year":"2005","unstructured":"Lalitha P, Rajagopalan J, Prakash K, Ramasamy K, Prajna NV, Srinivasan M. Postcataract endophthalmitis in South india: incidence and outcome. Ophthalmology. 2005;112(11):1884\u20139.","journal-title":"Ophthalmology"},{"issue":"8","key":"4479_CR18","doi-asserted-by":"publisher","first-page":"e71731","DOI":"10.1371\/journal.pone.0071731","volume":"8","author":"H Cao","year":"2013","unstructured":"Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS ONE. 2013;8(8):e71731.","journal-title":"PLoS ONE"},{"issue":"7","key":"4479_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamaophthalmol.2016.1351","volume":"134","author":"V Daien","year":"2016","unstructured":"Daien V, Papinaud L, Gillies MC, Domerg C, Nagot N, Lacombe S, Daures JP, Carriere I, Villain M. Effectiveness and safety of an intracameral injection of Cefuroxime for the prevention of endophthalmitis after cataract surgery with or without perioperative capsular rupture. JAMA Ophthalmol. 2016;134(7):810\u20136.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"4479_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ophtha.2017.01.038","volume":"124","author":"SG Schwartz","year":"2017","unstructured":"Schwartz SG, Flynn HW Jr, Moshfeghi DM, Davis JL. A new complication associated with the use of prophylactic intracameral antibiotics: hemorrhagic occlusive retinal vasculitis. Ophthalmology. 2017;124(5):578\u20139.","journal-title":"Ophthalmology"}],"updated-by":[{"DOI":"10.1186\/s12886-025-04557-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000}}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04479-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:49:12Z","timestamp":1765471752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04479-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04479-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12886-025-04557-z","URL":"https:\/\/doi.org\/10.1186\/s12886-025-04557-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study did not require ethics committee approval according to the Republic of T\u00fcrkiye, Regulation on Clinical Trials of Drugs and Biological Products (initially published in the Official Gazette No. 28030, 19 August 2011, and amended thereafter). Written informed consent to participate was obtained from all patients. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"662"}}